Results 261 to 270 of about 12,400,134 (300)
Some of the next articles are maybe not open access.

The Versatile Bacterial Type IV Secretion Systems [PDF]

open access: yesNature Reviews Microbiology, 2003
Bacteria use type IV secretion systems for two fundamental objectives related to pathogenesis--genetic exchange and the delivery of effector molecules to eukaryotic target cells. Whereas gene acquisition is an important adaptive mechanism that enables pathogens to cope with a changing environment during invasion of the host, interactions between ...
Peter J Christie, Eric Cascales
exaly   +4 more sources

Structural biology of bacterial secretion systems in gram-negative pathogens--potential for new drug targets.

open access: yesInfectious Diseases - Drug Targets, 2009
Gram-negative bacteria have evolved diverse secretion systems/machineries to translocate substrates across the cell envelope. These various machineries fulfil a wide variety of functions but are also essential for pathogenic bacteria to infect human or ...
É. Durand   +6 more
semanticscholar   +2 more sources

Antivirulence drugs to target bacterial secretion systems.

Current Opinion in Microbiology, 2010
The rise of resistance of pathogenic bacteria to antibiotics constitutes an increasing risk to public health. Environmental bacteria constitute a large reservoir of resistance determinants and it is predictable that resistance to more antibiotics will be acquired by even more pathogens in future.
C. Baron
semanticscholar   +3 more sources

Bacterial Defense against the Type VI Secretion System

Trends in Microbiology, 2021
Bacteria have evolved systems dedicated to interbacterial competition. Here we highlight defenses utilized by Gram-negative cells against type VI secretion system (T6SS)-wielding competitors, including physical barriers, genetically encoded antidotes, and stress responses.
Sophie, Robitaille   +2 more
openaire   +2 more sources

Redefining the bacterial Type I protein secretion system

2023
Type I secretion systems (T1SS) are versatile molecular machines for protein transport across the Gram-negative cell envelope. The archetypal Type I system mediates secretion of the Escherichia coli hemolysin, HlyA. This system has remained the pre-eminent model of T1SS research since its discovery.
Hodges, Freya J.   +4 more
openaire   +4 more sources

Protein secretion systems in bacterial pathogens

Frontiers in Biology, 2014
Many bacterial pathogens utilize specialized secretion systems to deliver virulence factors into the extracellular milieu. These exported effectors act to manipulate various processes of targeted cells in order to create a suitable niche for bacterial growth.
Li Xu, Yancheng Liu
openaire   +1 more source

The Type VI Secretion System: A Versatile Bacterial Weapon

open access: yesMicrobiology (United Kingdom), 2019
The Type VI secretion system (T6SS) is a protein nanomachine that is widespread in Gram-negative bacteria and is used to translocate effector proteins directly into neighbouring cells. It represents a versatile bacterial weapon that can deliver effectors into distinct classes of target cells, playing key roles in inter-bacterial competition and ...
Sarah J. Coulthurst
exaly   +4 more sources

Type IV secretion systems and their effectors in bacterial pathogenesis

Current Opinion in Microbiology, 2006
Type IV secretion systems (T4SSs) are membrane-associated transporter complexes used by various bacteria to deliver substrate molecules to a wide range of target cells. T4SSs are involved in horizontal DNA transfer to other bacteria and eukaryotic cells, in DNA uptake from or release into the extracellular milieu, in toxin secretion and in the ...
Backert, S., Meyer, T.
openaire   +3 more sources

Targeting Bacterial Secretion Systems: Benefits of Disarmament in the Microcosm

Infectious Disorders - Drug Targets, 2007
Secretion systems are used by many bacterial pathogens for the delivery of virulence factors to the extracellular space or directly into host cells. They are attractive targets for the development of novel anti-virulence drugs as their inactivation would lead to pathogen attenuation or avirulence, followed by clearance of the bacteria by the immune ...
Christian, Baron, Brian, Coombes
openaire   +2 more sources

Home - About - Disclaimer - Privacy